Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- 0 vs. Q1 2025
- Shares held
- 11.8M
- −6.56K (−0.1%) vs. Q1 2025
- Total value
- $22.9M
- +$13.5M (+142.3%) vs. Q1 2025
- New holders
- 10
- 10 more added
- Sold out
- 10
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 6 | $12 | 0.00% | +2+50.0% | Added |
| Bank of America Corp | 8 | $16 | 0.00% | −39,388−100.0% | Reduced |
| Oliver Lagore Vanvalin Investment Group | 100 | $80 | 0.00% | +100 | New |
| US Bancorp | 3,200 | $6.21K | 0.00% | 00.0% | Unchanged |
| Ancora Advisors, LLC | 10,000 | $19.4K | 0.00% | 00.0% | Unchanged |
| Taylor Financial Group, Inc. | 10,000 | $19.4K | 0.01% | +10,000 | New |
| Jones Financial Companies LLLP | 11,000 | $20.5K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 11,000 | $21.3K | 0.00% | +11,000 | New |
| LPL Financial LLC | 11,050 | $21.4K | 0.00% | −100,490−90.1% | Reduced |
| Federation des caisses Desjardins du Quebec | 13,000 | $25.2K | 0.00% | 00.0% | Unchanged |
| Beta Wealth Group, Inc. | 14,127 | $27.4K | 0.01% | 00.0% | Unchanged |
| Bay Rivers Group | 14,321 | $27.8K | 0.01% | +14,321 | New |
| Virtu Financial LLC | 14,761 | $29.0K | 0.00% | +14,761 | New |
| Journey Strategic Wealth LLC | 15,000 | $29.1K | 0.00% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 15,100 | $29.3K | 0.00% | +15,100 | New |
| Walleye Capital LLC | 15,109 | $29.3K | 0.00% | −76,811−83.6% | Reduced |
| Geode Capital Management, LLC | 17,958 | $34.8K | 0.00% | −1,914−9.6% | Reduced |
| State Street Corp | 18,246 | $35.4K | 0.00% | −291−1.6% | Reduced |
| National Bank of Canada | 18,700 | $36.1K | 0.00% | 00.0% | Unchanged |
| Scientech Research LLC | 19,064 | $37.0K | 0.01% | −3,854−16.8% | Reduced |
| Creative Planning | 23,410 | $45.4K | 0.00% | +10,000+74.6% | Added |
| Safeguard Investment Advisory Group, LLC | 25,044 | $48.6K | 0.01% | 00.0% | Unchanged |
| Group One Trading, L.P. | 31,616 | $61.3K | 0.00% | −106,744−77.1% | Reduced |
| Jane Street Group, LLC | 31,933 | $62.0K | 0.00% | +31,933 | New |
| Royal Bank of Canada | 35,600 | $69.0K | 0.00% | +25,600+256.0% | Added |
| Colony Group, LLC | 36,000 | $69.8K | 0.00% | +36,000 | New |
| Raymond James Financial Inc | 43,235 | $83.9K | 0.00% | +10,000+30.1% | Added |
| Northern Trust Corp | 53,001 | $102.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 63,369 | $122.9K | 0.00% | +1,309+2.1% | Added |
| Cascades Capital Asset Management, LLC | 67,135 | $130.2K | 0.07% | +67,135 | New |
| Goldman Sachs Group Inc | 119,449 | $231.7K | 0.00% | +119,449 | New |
| Valeo Financial Advisors, LLC | 130,699 | $253.6K | 0.01% | +110,699+553.5% | Added |
| XTX Topco Ltd | 160,963 | $312.3K | 0.01% | +108,959+209.5% | Added |
| UBS Group AG | 322,648 | $625.9K | 0.00% | +211,125+189.3% | Added |
| Bleichroeder LP | 500,000 | $970.0K | 0.24% | 00.0% | Unchanged |
| Lion Point Capital, LP | 548,806 | $1.06M | 7.23% | 00.0% | Unchanged |
| Toronto Dominion Bank | 750,000 | $1.46M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 820,421 | $1.59M | 0.00% | −148,104−15.3% | Reduced |
| Simplify Asset Management Inc. | 990,000 | $1.92M | 0.12% | +140,000+16.5% | Added |
| BML Capital Management, LLC | 1,136,091 | $2.20M | 1.69% | 00.0% | Unchanged |
| Alta Fundamental Advisers LLC | 1,398,977 | $2.71M | 1.48% | −28,502−2.0% | Reduced |
| Propel Bio Management, LLC | 1,791,557 | $3.48M | 4.22% | +340,000+23.4% | Added |
| RTW Investments, LP | 2,506,102 | $4.86M | 0.07% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −322,082−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −76,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −40,636−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −39,450−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −26,023−100.0% | Sold out |
| Clear Creek Financial Management, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,266−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |